Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Assets (2018 - 2025)

Historic Assets for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $4.4 billion.

  • AdaptHealth's Assets fell 193.32% to $4.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 billion, marking a year-over-year decrease of 193.32%. This contributed to the annual value of $4.5 billion for FY2024, which is 48.14% down from last year.
  • Latest data reveals that AdaptHealth reported Assets of $4.4 billion as of Q3 2025, which was down 193.32% from $4.4 billion recorded in Q2 2025.
  • Over the past 5 years, AdaptHealth's Assets peaked at $5.3 billion during Q1 2023, and registered a low of $4.4 billion during Q2 2025.
  • Its 5-year average for Assets is $4.8 billion, with a median of $4.7 billion in 2021.
  • Per our database at Business Quant, AdaptHealth's Assets soared by 57970.54% in 2021 and then plummeted by 1475.83% in 2024.
  • Over the past 5 years, AdaptHealth's Assets (Quarter) stood at $5.3 billion in 2021, then decreased by 0.59% to $5.2 billion in 2022, then fell by 13.62% to $4.5 billion in 2023, then decreased by 0.48% to $4.5 billion in 2024, then dropped by 2.3% to $4.4 billion in 2025.
  • Its last three reported values are $4.4 billion in Q3 2025, $4.4 billion for Q2 2025, and $4.4 billion during Q1 2025.